Lupin decides to divest his share of the Japanese company in the agreement

Nanomi, Lupin's subsidiary, makes a final agreement to divest all of its stake in Kyowa.

Pharma giant Lupin (including its affiliates, branded as Lupin) has announced that it has entered into a final agreement to sell its entire interest in its Japanese subsidiary Kyowa Pharmaceutical Industry Co. (Kyowa) to Unison Capital Partners IV, LPS and Unison Capital Partners IV (F). L.P. (Collectively known as Unison), Japan's leadin....